Banu Coskun Yilmaz

Banu Coskun Yilmaz

Auto-generated profile, based on publicly available information

Banu Coskun Yilmaz

Mersin University, Faculty of Medicine, Department of Histology and Embryology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2018 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
NCNecmiye Canacankatan
Necmiye Canacankatan
EDErdem Di̇nç
Erdem Di̇nç
DKDeniz Ki̇bar
Deniz Ki̇bar
CYCem Yalaza
Cem Yalaza
ŞAŞerife Efsun ANTMEN
Şerife Efsun ANTMEN
BTBahar Tasdelen
Bahar Tasdelen
Purpose: This study investigated the anti-inflammatory efficacy of topical application of a selective tyrosine kinase receptor inhibitor (TKI), Axitinib in experimental corneal neovascularization (CNV) model in rats. Vascular endothelial growth factor receptor 1 (VEGFR1), VEGFR2 and VEGFR3 were evaluated as angiogenic markers, nuclear factor kappa B (NF-κB), tumor necrosis factor α (TNFα) and cyclooxygenase-2 (COX2) were determined as inflammatory markers and also histopathological evaluations were carried out. Materials and Methods: Experimental CNV model was established by silver nitrate cauterization in right eye. 6 groups were included as Control; CNV; CNV+DMSO; CNV+0.04% Axitinib; CNV+0.08% Axitinib and CNV+0.24% Axitinib. The corneas were collected and VEGFR1, VEGFR2, VEGFR3, NF-κB, TNFα and COX2 were measured by ELISA. Results: Axitinib, significantly reduced corneal VEGFR1 and VEGFR2 compared to CNV. The most efficiency of Axitinib treatment was confirmed on VEGFR2 and especially with 0.04% dose. Increased NF-κB and TNFα level were reduced by 0.04% Axitinib treatment compared to CNV and CNV+DMSO. Conclusion: Axitinib may be suggested as a promising anti-inflammatory agent in CNV by suppressing corneal VEGFR1, VEGFR2, NF-κB and TNFα, beside improving the histological pattern.

14 May 2020 in Journal of Ankara University Faculty of Medicine
Verified
Journal Article
Open access
EAEmine Arık
Emine Arık
HDHabibullah Dolgun
Habibullah Dolgun
PBPınar Kuru Bektaşoğlu
Pınar Kuru Bektaşoğlu
JEJulide Ergil
Julide Ergil
BYBanu Coşkun Yılmaz
Banu Coşkun Yılmaz
BGBora Gürer
Bora Gürer

18 September 2023 in Medical Records
Verified
Journal Article
Closed access
PDF file
TMTuba Ozcan Metin
Tuba Ozcan Metin
GBGulsen Bayrak
Gulsen Bayrak
SYSelma YAMAN
Selma YAMAN
ADAdem Doğaner
Adem Doğaner
AYAtila YOLDAS
Atila YOLDAS
GGGulsah Gurbuz
Gulsah Gurbuz
Aim: Cisplatin (CP) is used to treat a variety of cancers as a chemotherapeutic agent. This drug has also severe side effects and its use exhibits serious toxicity in a number of organs, including kidney and heart. The aim of the present study was to evaluate the ultrastructural and inflammatory changes induced by CP treatment in rat cardiac tissue in a time-dependent manner. Material and Methods: Rats were randomly divided into three experimental groups; control (only saline), CP D2 (treated with CP 2.5 mg/kg/day for 2 days), and CP D7 (treated with CP 2.5 mg/kg/day for 7 days). Cardiac tissues were examined under an electron microscope. Inflammation markers including tumor necrosis factor-α (TNF-α) and interleukin 1β (IL-1β) were analyzed by immunohistochemistry. In addition, electrocardiography was performed to measure the electrical activity. Results: The ultrastructural analysis of the CP D7 group revealed that myofibrils were disrupted and disorganized, mitochondria degenerated, and interstitial edema developed. When compared to the control and CP D2 groups, there was a noticeable increase in the level of TNF-α and IL-1β expression in the CP D7 group according to immunohistochemistry results. Electrocardiography showed that RR interval was longer in CP D7 than CP D2 and control groups. Conclusion: CP for 7 days damaged the ultrastructural morphology in cardiac tissue. Therefore, these findings suggest that the potential therapeutic approaches to reduce mitochondrial damage and inflammation against toxicity caused by CP may provide for clinically significant prevention when using the drug for an extended period of time.

1 January 2024 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
EEErim Erdem
Erim Erdem
MCMustafa Kaplan Caliskan
Mustafa Kaplan Caliskan
MKMeryem Ilkay Karagul
Meryem Ilkay Karagul
EAErdem Akbay
Erdem Akbay
BYBanu Coskun Yilmaz
Banu Coskun Yilmaz
YAYuksel Cem Aygun
Yuksel Cem Aygun
Erdem E, et al. Investig Clin Urol. 2024 Mar;65(2):180-188. https://doi.org/10.4111/icu.20230034

15 April 2018 in Mersin Üniversitesi Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
SDSerra Sürmeli Döven
Serra Sürmeli Döven
STSelçuk Teke
Selçuk Teke
IGİcLal Gürses
İcLal Gürses
BYBanu Coşkun Yılmaz
Banu Coşkun Yılmaz
EBEbru Balli
Ebru Balli
ADAli Delibaş
Ali Delibaş
Amaç: Alport sendromu hematüri, ilerleyici böbrek yetmezliği, işitme kaybı ve oküler anormalliklerle seyreden bir hastalıktır. Bu çalışmada merkezimizde Alport sendromu tanısıyla izlenen hastaların demografik, klinik ve laboratuvar bulguları ile renal biyopsilerinin histopatolojik ve elektron mikroskobik bulgularının değerlendirilmesi amaçlanmıştır. Yöntem: Çocuk Nefroloji Kliniğinde Haziran 2004 ile Ocak 2018 tarihleri arasında takip edilen 14 Alport sendromlu hastanın başvuru şikayetleri, aile hikayesi, renal tutulumu, göz ve işitme bulguları, böbrek biyopsilerinin histopatolojik ve elektron mikroskobik değerlendirmeleri geriye dönük olarak incelendi. Bulgular: Yedisi kız ve yedisi erkek olmak üzere toplam 14 hasta değerlendirildi. Hastaların yaşları 15 ay-17 yıl arasındaydı (ortalama 10.7±3.8 yıl). On bir hasta hematüri, bir hasta vücutta şişlik, iki hasta ise şikâyeti olmaksızın ailelerinde Alport sendromu öyküsü olması nedeniyle araştırılmak üzere başvurdu. Anne-baba arasında akrabalık beş hastada bulunurken, 11 hastanın ailesinde Alport sendromu öyküsü mevcuttu. Sensorinöral işitme kaybı yedi hastada saptandı. Bilateral anterior lentikonus son dönem böbrek yetmezliği kliniğinde başvuran bir hastada saptandı. Böbrek biyopsisi yapılan 10 hastanın elektron mikroskobik incelenmesinde, tüm vakalarda glomerül bazal membranında incelmeler, kalınlaşmalar ve sepet görünümü ile karakterize düzensizlikler gösterildi. Sonuç: Hematüri şikayetiyle başvuran hastalarda aile öyküsünün sorgulanması, göz muayenesi ve işitme testlerinin yapılması Alport sendromu tanısını koymada yol gösterici olmaktadır. Elektron mikroskobide glomerul bazal membrandaki tipik değişikliklerin görülmesi tanıyı kesinleştirmektedir.

5 April 2022 in European Journal of Therapeutics
Verified
Journal Article
Open access
DGDeniz Gazel
Deniz Gazel
MEMehmet Erinmez
Mehmet Erinmez
HDHadiye Demirbakan
Hadiye Demirbakan
BYBanu Coskun Yilmaz
Banu Coskun Yilmaz
Proteus mirabilis,transmission electron microscopy,protocol